| Literature DB >> 32564019 |
Makoto Samukawa1, Naoko Nakamura2, Makito Hirano3, Miyuki Morikawa1, Hanami Sakata1, Ichizo Nishino4, Rumiko Izumi2, Naoki Suzuki2, Hiroshi Kuroda2, Kensuke Shiga5,6, Kazumasa Saigoh1, Masashi Aoki2, Susumu Kusunoki1.
Abstract
Mutations in the PNPLA2 gene cause neutral lipid storage disease with myopathy (NLSDM) or triglyceride deposit cardiomyovasculopathy. We report a detailed case study of a 53-year-old man with NLSDM. The PNPLA2 gene was analyzed according to the reported method. We summarized the clinical, laboratory, and genetic information of 56 patients, including our patient and 55 other reported patients with homozygous or compound heterozygous mutations in the PNPLA2 gene. We found a novel homozygous mutation (c.194delC) in the PNPLA2 gene that resulted in frameshift. The patient suffered from normal-tension glaucoma and pulmonary cysts, symptoms that are relatively common in the elderly but were not previously reported for this disease. Our summary confirmed that Jordan's anomaly, polymorphonuclear leukocytes with lipid accumulation, was the most consistent finding of this disease. Because this disease is potentially treatable, our results may help rapid and correct diagnosis.Entities:
Keywords: Genotype-phenotype correlation; Glaucoma; Neutral lipid storage disease with myopathy; PNPLA2; Pulmonary cysts; Triglyceride deposit cardiomyovasculopathy
Mesh:
Substances:
Year: 2020 PMID: 32564019 PMCID: PMC7592920 DOI: 10.1159/000508346
Source DB: PubMed Journal: Eur Neurol ISSN: 0014-3022 Impact factor: 1.710